SymBio Pharmaceuticals Limited (4582) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

SymBio Pharmaceuticals Limited (4582) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SymBio Pharmaceuticals Limited (4582) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
SymBio Pharmaceuticals Limited (4582) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
23 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

SymBio Pharmaceuticals Limited (SymBio) is a biopharmaceutical company that conducts research and development, and manufactures new drug candidates. The company develops SyB drugs, treakisym and rigosertib, among others. It offers business development in areas of oncology, hematology and pain-management areas. SymBio introduce new drug candidates that expands new pipelines. The company offers pipeline products in forms of pain management drugs, anti cancer agents, IV anti cancer agents and oral anti cancer agents. It manufactures and markets its drugs with the help of domestic and foreign pharmaceutical companies. SymBio is headquartered in Tokyo, Japan

SymBio Pharmaceuticals Limited (4582) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company&l

  
Source:
Document ID
GDPH83273D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
SymBio Pharmaceuticals Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
SymBio Pharmaceuticals Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
SymBio Pharmaceuticals Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
SymBio Pharmaceuticals Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
SymBio Pharmaceuticals Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
SymBio Pharmaceuticals Limited, Pharmaceuticals &Healthcare, Deal Details1010
  Venture Financing101
    SymBio Pharma Secures US$24.5 Million In Series E Financing Round102
    SymBio Pharma Secures US$8 Million In Second Tranche Of Series D Financing121
  Licensing Agreements131
    SymBio Pharma Enters into Licensing Agreement with The Medicines Company131
    SymBio Pharma Amends its Licensing Agreement with Onconova Therapeutics for Rigosertib142
    SymBio Pharma Enters Into Licensing Agreement With Cephalon161
  Equity Offering171
    SymBio Pharma Completes IPO Of Common Stock For US$37.1 Million172
  Debt Offering191
    Symbio Pharma Completes Private Placement Of Bonds Due 2016 For US$12 Million191
SymBio Pharmaceuticals Limited - Key Competitors201
Key Employees211
Locations And Subsidiaries221
  Head Office221
  Other Locations &Subsidiaries221
Appendix231
  Methodology231
  About GlobalData231
  Contact Us231
  Disclaimer231

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "SymBio Pharmaceuticals Limited (4582) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/SymBio-Pharmaceuticals-Limited-4582-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7766>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). SymBio Pharmaceuticals Limited (4582) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/SymBio-Pharmaceuticals-Limited-4582-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7766>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research